Literature DB >> 29650687

The Eighth Edition of TNM Staging of Lung Cancer: Reference Chart and Diagrams.

Omar Lababede1, Moulay A Meziane2.   

Abstract

Lung cancer is the leading cause of cancer-related mortality in the U.S. TNM staging of lung cancer is implemented to define the extent of disease and consequently assign prognosis and guide treatment. The newest edition of TNM staging of lung cancer has been released recently. In this article, we present the TNM staging of lung cancer in a concise, yet comprehensive, visual format. © AlphaMed Press 2018.

Entities:  

Mesh:

Year:  2018        PMID: 29650687      PMCID: PMC6058324          DOI: 10.1634/theoncologist.2017-0659

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  3 in total

Review 1.  Seventh edition of the cancer staging manual and stage grouping of lung cancer: quick reference chart and diagrams.

Authors:  Omar Lababede; Moulay Meziane; Thomas Rice
Journal:  Chest       Date:  2011-01       Impact factor: 9.410

2.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

3.  The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.

Authors:  Peter Goldstraw; Kari Chansky; John Crowley; Ramon Rami-Porta; Hisao Asamura; Wilfried E E Eberhardt; Andrew G Nicholson; Patti Groome; Alan Mitchell; Vanessa Bolejack
Journal:  J Thorac Oncol       Date:  2016-01       Impact factor: 15.609

  3 in total
  15 in total

1.  Role of the EGFR-KDD mutation as a possible mechanism of acquired resistance of non-small cell lung cancer to EGFR tyrosine kinase inhibitors: A case report.

Authors:  Cheng He; Yong Wang
Journal:  Mol Clin Oncol       Date:  2021-12-10

2.  A Prognostic Model of Non-Small Cell Lung Cancer With a Radiomics Nomogram in an Eastern Chinese Population.

Authors:  Lijie Wang; Ailing Liu; Zhiheng Wang; Ning Xu; Dandan Zhou; Tao Qu; Guiyuan Liu; Jingtao Wang; Fujun Yang; Xiaolei Guo; Weiwei Chi; Fuzhong Xue
Journal:  Front Oncol       Date:  2022-06-14       Impact factor: 5.738

3.  An Artificial Intelligence Model for Predicting 1-Year Survival of Bone Metastases in Non-Small-Cell Lung Cancer Patients Based on XGBoost Algorithm.

Authors:  Zhangheng Huang; Chuan Hu; Changxing Chi; Zhe Jiang; Yuexin Tong; Chengliang Zhao
Journal:  Biomed Res Int       Date:  2020-06-27       Impact factor: 3.411

4.  Comparative study of imaging and pathological evaluation of pneumonic mucinous adenocarcinoma.

Authors:  Jun Han; Chongchong Wu; Yuxin Wu; Hui Deng; Jie Gao; Hua Han; Xinying Xue
Journal:  Oncol Lett       Date:  2020-12-17       Impact factor: 2.967

5.  Successful Treatment of Synchronous Double Lung Primary Malignancies and Colon Cancer.

Authors:  Hosam A Alghanmi
Journal:  Cureus       Date:  2022-02-23

Review 6.  Current Surgical Indications for Non-Small-Cell Lung Cancer.

Authors:  Nathaniel Deboever; Kyle G Mitchell; Hope A Feldman; Tina Cascone; Boris Sepesi
Journal:  Cancers (Basel)       Date:  2022-02-28       Impact factor: 6.639

7.  Comprehensive genomic profiling aids in understanding the lesion origins of a patient with six synchronous invasive lung adenocarcinomas: a case study.

Authors:  Yang Song; Ziqi Jia; Pancheng Wu; Weiwei Wang; Qiuxiang Ou; Hua Bao; Man Yu; Xue Wu; Peng Liu; Naixin Liang; Shuyang Zhang; Shanqing Li
Journal:  BMC Pulm Med       Date:  2020-04-03       Impact factor: 3.317

8.  Dynamic nomograms combining N classification with ratio-based nodal classifications to predict long-term survival for patients with lung adenocarcinoma after surgery: a SEER population-based study.

Authors:  Suyu Wang; Yue Yu; Wenting Xu; Xin Lv; Yufeng Zhang; Meiyun Liu
Journal:  BMC Cancer       Date:  2021-08-04       Impact factor: 4.430

9.  Pretreatment neutrophil-to-lymphocyte ratio is a predictive biomarker for EGFR TKI-treated patients with advanced EGFR-mutant Non-small cell lung cancer.

Authors:  Cong Xu; Xiaojun Yao; Ting Li; Jue Wang; Bo An; Jing Wang; Xinbing Sui; Elaine Lai-Han Leung; Qibiao Wu
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

10.  Development and Validation of a Risk Prediction Model for Venous Thromboembolism in Lung Cancer Patients Using Machine Learning.

Authors:  Haike Lei; Mengyang Zhang; Zeyi Wu; Chun Liu; Xiaosheng Li; Wei Zhou; Bo Long; Jiayang Ma; Huiyi Zhang; Ying Wang; Guixue Wang; Mengchun Gong; Na Hong; Haixia Liu; Yongzhong Wu
Journal:  Front Cardiovasc Med       Date:  2022-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.